Strategies for regulation of innovative non-vaccine biologics for disease prevention in China: a SWOT analysis
With globally increasing diversification of biomedical technologies, a large number of innovative biologics, such as long-acting monoclonal antibodies, have shown good preventive effects in clinical trials. However, in accordance with current legal framework in China, such biologics cannot be regist...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Libro |
| Pubblicazione: |
Editorial Office of Chinese Journal of Public Health,
2024-01-01T00:00:00Z.
|
| Soggetti: | |
| Accesso online: | Connect to this object online. |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Accesso online
Connect to this object online.3rd Floor Main Library
| Collocazione: |
A1234.567 |
|---|---|
| Copia 1 | Disponibile |